Research Reports

Healthcare

icon
Home » Reports » Global Diabetic Footwear Shoes Market Analysis Opportunity Outlook 2024
Market Research Report

Global Diabetic Footwear (Shoes) Market Analysis & Opportunity Outlook 2024

Published On : 10:33 PM, 3rd September, 2018 REP-ID-51 Category: Healthcare

Diabetic Footwear (Shoes) Market Overview

Diabetes is a prolonged medical condition, which is caused by low levels of insulin in the body. A person suffering from diabetes is more prone to develop wounds, ulcers or lack of sensation in any part of his body, particularly in his feet. Diabetic/therapeutic shoes have evolved as a medical revolution as it aids in preventing the feet of a diabetic person from developing any injuries or wounds with the help of its unique design and therapeutic properties.

Market Size and Forecast

The global diabetic footwear (shoes) market is anticipated to flourish at a CAGR of 8.3% over the forecast period i.e. 2017-2024. Further, the market of diabetic footwear (shoes) market was valued at USD 16.05 Billion in 2016 and is projected to garner USD 24.5 Billion by the end of 2024. Factor such as, rising prevalence of diabetes, rise in spending on diabetes treatment is anticipated to drive the growth of the global diabetic footwear (shoes) market over the forecast period. According to IDF (International Diabetes Federation), the total adult (age 20-79 years) diabetic population is projected to expand from 415 million in 2015 to 642 million by 2040.

In the regional market, North America is anticipated to account for a significant portion of market share in the overall market of global diabetic footwear (shoes) market over the forecast period. Further, factor such as rising ageing population is expected to increase the growth of North America diabetic footwear (shoes) market during the forecast period. Moreover, According to the Center for Disease Control and Prevention (CDC), it is estimated that one out of every three adults in the U.S. would suffer from diabetes by the end of 2050. Furthermore, rise in number of diabetic cases is expected to be the largest diabetic footwear (shoes) market in North America followed by Canada in the upcoming years.

diabetic Footwear market

Europe diabetic footwear (shoes) market is expected to witness substantial growth over the forecast period. Factor such as, increasing obesity levels is anticipated to drive the growth of diabetic footwear market in Europe in the upcoming years. Further, Asia-Pacific is poised to record the fastest growth over the global diabetic footwear (shoes) market over the forecast period. Factor such as, Growth in the aging population and strengthening economic condition is anticipated to drive the growth of the diabetic footwear (shoes) Market in Asia Pacific during the forecast period.

Based on end user, diabetic footwear (shoes) market is segmented into, male and female, out of which, male segment is expected to dominate the growth of the global diabetic footwear (shoes) market during the forecast period.

Market Segmentation

Our in-depth analysis has segmented global diabetic footwear (shoes) market into the following segments:

By Distribution Channel

  • Off-Line Distribution Channels
    • Shoe Stores
    • Departmental Stores
    • Medical Specialty Stores
    • Others
  • On-Line Distribution Channels

By End User

  • Male
  • Female

By Inpatient and Outpatient

  • Inpatient
  • Outpatient

By Region

Global diabetic footwear (shoes) market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Russia, Turkey, BENELUX, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Australia, New Zealand, Malaysia & Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and North Africa (GCC, Israel, North Africa, South Africa & Rest of Middle East) Market Size and Y-O-Y Growth Analysis

Diabetic footwear market size

Growth Drivers and Challenges

Factor such as, rise in the prevalence of diabetes amongst global population across the globe is anticipated to intensify the growth of the global diabetic footwear (shoes) market during the forecast period. For instance, the global incidence of diabetes among adults was 6.6% in 2010, which rose to 9.2% in 2014. In addition, growth in the ageing population estimated to positively drive the growth of the diabetic footwear (shoes) market over the forecast period.

Apart from this, increasing demand of customized diabetic footwear is anticipated to be the dynamic factor behind the growth of the diabetic footwear (shoes) market. Further, rise in spending on diabetes treatment is expected to supplement the growth of the global diabetic footwear (shoes) market over the forecast period.

However, high cost of diabetic footwear and lack of awareness are some of the key factors which are expected to limit the growth of global diabetic footwear (shoes) market in upcoming years.

Key Players

  • DARCO International Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Sigvaris
  • Ortho Europe
  • Duna Srl
  • Thuasne
  • Medline Industries
  • DJO Global Inc.
  • Hong Kong Grace Shoes Development Co Ltd.
  • Dr. Zen Inc.
  • Drew Shoe Corporation USA

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The global diabetic footwear (shoes) market is segmented as follows:

  • By Distribution Channel Market Size & Y-O-Y Growth Analysis
  • By End User Market Size & Y-O-Y Growth Analysis
  • By Inpatient and Outpatient Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

key Answers

1. List of Figures
2. List of Tables 
3. Executive Summary 
4. Research Methodology 
5. Global Diabetic Footwear Market Size and Forecast 
6. Market Segmentation
6.1 By Regions
6.1.1 North America Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.1 U.S. Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.2 Canada Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.3 Mexico Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.1.4 Market Attractiveness of North America
6.1.1.5 BPS Analysis of North America
6.1.2 Europe Market Size ($ Milion) & Y-O-Y Growth Analysis, 2015-2021
6.1.2.1 U.K. Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.2 Germany Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.3 France Market Size ($ Milion) & Y-O-Y Growth Analysis, 2015-2021
6.1.2.4 Spain Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.5 Italy Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.6 Hungary Market Size ($  Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.7 Benelux (Belgium, Netherlands and Luxembourg) Market Size ($ Milion) & Y-O-Y Growth Analysis (%), 2015-2021
6.1.2.8 Market Attractiveness of Europe
6.1.2.9 BPS Analysis of Europe
6.1.3 Russia Market Size ($) & Y-O-Y Growth Analysis, 2015-2021
6.1.4 Asia Pacific Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.1 India Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.2 China Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.3 Singapore Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.4 Japan Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.4.5 Market Attractiveness of Asia-Pacific
6.1.4.6 BPS Analysis of Asia Pacific
6.1.5 MENA Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.6 Latin America Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7 Oceanic Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7.1 Australia Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7.2 New Zealand Market Size ($) & Y-O-Y Growth Analysis (% Milion), 2015-2021
6.1.7.3 Market Attractiveness of Oceanic region
6.1.7.4 BPS Analysis of Oceanic Region
6.2 By Demography
6.3 By Inpatient and Outpatient
6.4 By Retail Distribution 

7. Porter’s Five Force Model Analysis 

8. Industry Growth Drivers
8.1 Rise in prevalence of diabetes in the world
8.1.1 Impact Analysis
8.2 Growth in the aging population
8.2.1 Impact Analysis
8.3 Increasing demand of customized diabetic footwear
8.3.1 Impact Analysis
8.4 Rise in spending on diabetes treatment
8.4.1 Impact Analysis

9. Restraints
9.1 High cost of diabetic footwear
9.1.1 Impact Analysis
9.2 Lack of awareness
9.2.1 Impact Analysis

10. Risk Analysis
10.1 Supply Risk -Medium
10.2 Demand Risk -Medium

11. Competitive Landscape
11.1 DARCO International Inc.
11.1.1 Company Overview
11.1.2 Products and Services
11.1.3 Key Financials
11.1.4 Recent News and Developments
11.2 Sigvaris
11.2.1 Company Overview
11.2.2 Products and services
11.2.3 Key Financials
11.2.4 Recent News and Developments
11.3 Ortho Europe
11.3.1 Company Overview
11.3.2 Products and Services
11.3.3 Key Financials
11.3.4 Recent news and developments
11.4 Duna Srl
11.4.1 Company Overview
11.4.2 Products and services
11.4.3 Key Financials
11.4.4 Recent News & Developments
11.5 Thuasne
11.5.1 Company Overview
11.5.2 Products and Services
11.5.3 Key Financials
11.5.4 Recent news & developments
11.6 Medline Industries
11.6.1 Company Overview
11.6.2 Products and services
11.6.3 Key Financials
11.6.4 Recent news & Developments
11.7 DJ Global Inc.
11.7.1 Company Overview
11.7.2 Products and services
11.7.3 Key Financials
11.7.4 Recent news & developments
11.8 Hong Kong Grace Shoes Development Co Ltd.
11.8.1 Company Overview
11.8.2 Products and services
11.8.3 Key Financials
11.8.4 Recent news & developments
11.9 Dr. Zen Inc.
11.9.1 Company Overview
11.9.2 Products and services
11.9.3 Key Financials
11.9.4 Recent news & developments
11.10 Supad
11.10.1 Company Overview
11.10.2 Products and services
11.10.3 Key Financials
11.10.4 Recent news & developments
11.11 Drew Shoe Corporation USA
11.11.1 Company Overview
11.11.2 Products and Services
11.11.3 Key Financials
11.11.4 Recent news & Developments
11.12 Podartis Srl
11.12.1 Company Overview
11.12.2 Products and Services
11.12.3 Key Financials
11.12.4 Recent news & developments
11.13 Aetrex Worldwide, Inc.
11.13.1 Company overview
11.13.2 Products and Services
11.13.3 Key Financials
11.13.4 Recent news & developments 

List of Figures:
Figure 5-1: Global Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 5-2: Total number of diabetic patients (age 20-79 years) in the world
Figure 6-1: The U.S. Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-2: Number of diabetic population (in millions) in the U.S., 2010-2014
Figure 6-3: Major causes of amputations in U.S.
Figure 6-4: Canada Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-5: Total number of diabetic patients in Canada (age > 12)
Figure 6-6: Total health expenditure (USD Millions) in Canada during 2010-2014
Figure 6-7: Mexico Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-8: Total number of diabetic patients in Mexico (age 20-79 years), 2014-2021
Figure 6-9: North America Market Attractiveness
Figure 6-10: North America BPS Analysis
Figure 6-11: U.K. Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-12: Germany Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-13: Diabetes prevalence % in Germany (age 20-79) years during 2013-2035
Figure 6-14: France Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-15: Total number of diabetic patients (age-20-79 years) in France 2013-2030
Figure 6-16: Spain Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-17: % of people (having diabetes type 2) suffering from other diseases in Spain
Figure 6-18: Italy Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-19: Total number of diabetic patients (in millions) in Italy (age 20-79 years)
Figure 6-20: % distribution of budget on diabetes by Italy
Figure 6-21: Hungary Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-22: Belgium Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-23: Netherlands Diabetic footwear market size (USD Millions) and Y-O-Y growth (%)
Figure 6-24: Luxembourg Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-25: Europe Market Attractiveness
Figure 6-26: Europe BPS Analysis
Figure 6-27: Russia Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-28: Total number of diabetic patients (age 20-79 years) in Russia, 2013-2021
Figure 6-29: India Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-30: Total number of diabetic patients (in millions) in India (age 20-79 years), 2007-2030
Figure 6-31: % of types of foot ulcers in India
Figure 6-32: China Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-33: Total number of diabetic patients (in millions) in China (age 20-79 years), 2013-2035
Figure 6-34: Singapore Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-35: Japan Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-36: Total number of diabetic population (age 20-79 years) in Japan, 2011-2014
Figure 6-37: % share of population according to age group in Japan
Figure 6-38: Asia-Pacific Market Attractiveness
Figure 6-39: Asia-Pacific BPS Analysis
Figure 6-40: MENA Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-41: Diabetes prevalence rates by country in MENA, 2014
Figure 6-42: Latin America Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-43: Australia Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-44: Australia Diabetic footwear market size (USD Millions) and Y-O-Y growth
Figure 6-45: Real gross national disposable income per person (USD ‘000’) in New Zealand,
Figure 6-46: Oceanic Region Market Attractiveness
Figure 6-47: Oceanic Region BPS Analysis
Figure 6-48: % market share by demography in 2014
Figure 6-49: % market share by demography in 2021
Figure 6-50: % of male and female diabetic population in the U.S.
Figure 6-51: % of male and female diabetic population in Canada
Figure 6-52: % of male and female diabetic population in Europe (age>25)
Figure 6-53: % of male and female diabetic population in the United Kingdom
Figure 6-54: % of male and female diabetic population in India
Figure 6-55: % of adult male and female diabetic population in China
Figure 6-56: % market share by inpatient and outpatient in 2014
Figure 6-57: % market share by inpatient and outpatient in 2021
Figure 6-58: Annual health spending (per capita) % growth in Germany
Figure 6-59: % market share by retail distribution in 2014
Figure 6-60: % market share by retail distribution in 2021
Figure 6-61: % market share by medical specialty and street stores in 2014
Figure 6-62: % market share by medical specialty and street stores in 2021
Figure 6-63: Sales of online stores in the U.S. from 2014-2016E (USD Billions)
Figure 6-64: Sales of departmental stores in the U.S. (USD Billions) during 2011-2015
Figure 6-65: % share of online retail outlets in Europe by country in 2015
Figure 6-66: E-commerce % share of total retail sales, India and China (2013-2017)
Figure 6-67: E-commerce market size of U.A.E., Saudi Arabia and Egypt forecast to 2020
Figure 6-68: E-commerce market size in Brazil, Argentina and Mexico, forecast to 2019
Figure 7-1: Porter`s Five Force Model, 2016 

List of Tables:
Table 5-1: Ranking of countries in terms of adult (age 20-79 years) diabetic population (in millions) in 2015 and 2040
Table 5-2: Ranking of countries in terms of diabetes related health expenditure (USD Billions) in 2015 and 2040
Table 6-1: Diabetes prevalence % in major countries of U.K. (2012-13)
Table 11-1: DJO Global key financials (USD Millions), 2012-2014
Table 11-2: DJO Global net sales by products (USD Millions), 2012-2014
Table 11-3: DJO Global net sales by country (USD Millions), 2012-2014
Table 6-1: Diabetes prevalence % in major countries of U.K. (2012-13)
Table 11-1: DJO Global key financials (USD Millions), 2012-2014
Table 11-2: DJO Global net sales by products (USD Millions), 2012-2014
Table 11-3: DJO Global net sales by country (USD Millions), 2012-2014

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2018 Research Nester. All rights reserved

Top